Company intelligence / Profile preview

Dash Pharms

Upper Saddle River, New Jersey, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Dash Pharmaceuticals is a specialty pharmaceutical company focused on the development, sourcing, and marketing of generic prescription drug products. The company manages a diverse portfolio of FDA-approved generics across multiple therapeutic areas, including pain management, anti-infectives, and gastrointestinal health. Dash Pharms operates by leveraging strategic manufacturing partnerships to bring high-quality, cost-effective medications to the United States market. Their business model emphasizes supply chain reliability and regulatory compliance to serve retail pharmacies, wholesalers, and healthcare providers.

Therapeutic areas: GastroenterologyNeurologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Dash Pharms.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dash Pharms.

Explore the full profile